{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:10:03Z","timestamp":1784783403235,"version":"3.55.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012706","name":"Uniwersytet Warmi\u0144sko-Mazurski w Olsztynie","doi-asserted-by":"publisher","award":["61.610.08\u2013110"],"award-info":[{"award-number":["61.610.08\u2013110"]}],"id":[{"id":"10.13039\/501100012706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012706","name":"Uniwersytet Warmi\u0144sko-Mazurski w Olsztynie","doi-asserted-by":"publisher","award":["This work was funded by the Minister of Science under \u201cThe Regional Initiative of Excellence Program\""],"award-info":[{"award-number":["This work was funded by the Minister of Science under \u201cThe Regional Initiative of Excellence Program\""]}],"id":[{"id":"10.13039\/501100012706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a major global health challenge, characterised by a heterogeneous clinical spectrum. While metabolomic studies have identified disruptions in amino acid, lipid, nucleotide, and energy metabolism during COVID-19, these investigations often lack fine-grained clinical stratification. In this study, we performed untargeted metabolomic profiling of plasma from 25 participants, including five healthy controls and twenty COVID-19 patients classified into four severity groups (COV1\u2013COV4) based on pulmonary involvement and the need for respiratory support. Using ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS), 541 metabolites were detected and analysed across all samples. Principal component analysis revealed a progressive metabolic divergence corresponding to disease severity. Monocarboxylic acid dysregulation was predominant in early to moderate cases (COV1\u2013COV3), whereas severe disease (COV4) demonstrated a shift toward pyrimidine metabolism enrichment, consistent with heightened nucleotide turnover driven by viral replication and immune cell proliferation. Phenylalanine metabolism emerged as a consistently enriched pathway in COV1\u2013COV3, suggesting aromatic amino acid perturbations as early markers of metabolic stress and immune activation. In contrast, pyrimidine pathway activation in COV4 could reflect profound systemic metabolic reprogramming associated with critical illness. These findings provide novel insights into COVID-19 pathophysiology, highlighting stage-specific metabolic signatures and potential biomarkers for disease monitoring. Our results support the concept of metabolomics-guided precision medicine, offering a rationale for targeted therapeutic interventions based on disease stage and metabolic phenotype.<\/jats:p>","DOI":"10.1371\/journal.pone.0352437","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:27:13Z","timestamp":1782408433000},"page":"e0352437","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severity-dependent metabolic rewiring in COVID-19 based on untargeted metabolomic profiling of patient plasma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-6929","authenticated-orcid":true,"given":"Marta","family":"Majewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz A.","family":"Ma\u017adziarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Lepiarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Wiszpolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Moczulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"\u0141opie\u0144ska-Biernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Iwanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kocbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Galtung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Gromadzi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"pone.0352437.ref001","doi-asserted-by":"crossref","first-page":"105114","DOI":"10.1016\/j.micpath.2021.105114","article-title":"Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach","volume":"158","author":"STR Moolamalla","year":"2021","journal-title":"Microb Pathog"},{"issue":"1","key":"pone.0352437.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and Metabolomic Characterization of COVID-19 Patient Sera","volume":"182","author":"B Shen","year":"2020","journal-title":"Cell"},{"issue":"6","key":"pone.0352437.ref003","article-title":"Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19","volume":"183","author":"Y Su","year":"2020","journal-title":"Cell"},{"issue":"1","key":"pone.0352437.ref004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41538-024-00261-2","article-title":"Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID","volume":"8","author":"AS Naidu","year":"2024","journal-title":"NPJ Sci Food"},{"issue":"15","key":"pone.0352437.ref005","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2174\/13816128113199990489","article-title":"Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors","volume":"20","author":"N-HT Dang","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"1","key":"pone.0352437.ref006","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11306-021-01859-3","article-title":"Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome","volume":"18","author":"I Roberts","year":"2021","journal-title":"Metabolomics"},{"issue":"7","key":"pone.0352437.ref007","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/nsr\/nwaa086","article-title":"Plasma metabolomic and lipidomic alterations associated with COVID-19","volume":"7","author":"D Wu","year":"2020","journal-title":"Natl Sci Rev"},{"issue":"14","key":"pone.0352437.ref008","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140327","article-title":"COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status","volume":"5","author":"T Thomas","year":"2020","journal-title":"JCI Insight"},{"key":"pone.0352437.ref009","article-title":"Large-scale multi-omic analysis of COVID-19 severity","volume":"12","author":"KA Overmyer","year":"2021","journal-title":"Cell Syst"},{"key":"pone.0352437.ref010","article-title":"Metabolomics profiling of critically ill coronavirus disease 2019 patients: identification of diagnostic and prognostic biomarkers","volume":"2","author":"DD Fraser","year":"2020","journal-title":"Crit Care Explor"},{"issue":"11","key":"pone.0352437.ref011","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/metabo14110617","article-title":"Metabolomic Insights into COVID-19 Severity: A Scoping Review","volume":"14","author":"E Pimentel","year":"2024","journal-title":"Metabolites"},{"issue":"2","key":"pone.0352437.ref012","article-title":"Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19","volume":"296","author":"HYF Wong","year":"2020","journal-title":"Radiology"},{"key":"pone.0352437.ref013","author":"COVID-19 Treatment Guidelines Panel","year":"2019"},{"key":"pone.0352437.ref014"},{"key":"pone.0352437.ref015","article-title":"Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis","volume":"32","author":"JW Song","year":"2020","journal-title":"Cell Metabolism"},{"issue":"9","key":"pone.0352437.ref016","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ajcn\/29.9.997","article-title":"The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection","volume":"29","author":"RW Wannemacher","year":"1976","journal-title":"Am J Clin Nutr"},{"key":"pone.0352437.ref017","doi-asserted-by":"crossref","first-page":"108313","DOI":"10.1016\/j.intimp.2021.108313","article-title":"Phenylalanine and COVID-19: Tracking disease severity markers","volume":"101","author":"RL Luporini","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"pone.0352437.ref018","doi-asserted-by":"crossref","first-page":"103068","DOI":"10.1016\/j.redox.2024.103068","article-title":"Exploring and disentangling the production of potentially bioactive phenolic catabolites from dietary (poly)phenols, phenylalanine, tyrosine and catecholamines","volume":"71","author":"MN Clifford","year":"2024","journal-title":"Redox Biol"},{"issue":"27","key":"pone.0352437.ref019","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1080\/10408398.2024.2410874","article-title":"A critical examination of human data for the biological activity of phenolic acids and their phase-2 conjugates derived from dietary (poly)phenols, phenylalanine, tyrosine and catecholamines","volume":"65","author":"G Williamson","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"key":"pone.0352437.ref020","article-title":"Aromatic amino acid metabolites: molecular messengers bridging immune-microbiota communication","volume":"25","author":"HK Shin","year":"2025","journal-title":"Immune Network"},{"key":"pone.0352437.ref021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-3-031-07395-3_64","article-title":"Serum aromatic microbial metabolites as biological markers in intensive care","volume-title":"Biomarkers in trauma, injury and critical care","author":"NV Beloborodova","year":"2023"},{"key":"pone.0352437.ref022","doi-asserted-by":"crossref","first-page":"684961","DOI":"10.3389\/fonc.2021.684961","article-title":"Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine","volume":"11","author":"W Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0352437.ref023","article-title":"Large-Scale Multi-omic Analysis of COVID-19 Severity","volume":"12","author":"KA Overmyer","year":"2021","journal-title":"Cell Syst"},{"issue":"7","key":"pone.0352437.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"M Sa Ribero","year":"2020","journal-title":"PLoS Pathog"},{"issue":"3","key":"pone.0352437.ref025","article-title":"Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1\u03b1\/Glycolysis-Dependent Axis","volume":"32","author":"AC Codo","year":"2020","journal-title":"Cell Metab"},{"key":"pone.0352437.ref026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Y Zhou","year":"2020","journal-title":"Cell Discov"},{"issue":"10","key":"pone.0352437.ref027","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s13238-020-00768-w","article-title":"Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2","volume":"11","author":"R Xiong","year":"2020","journal-title":"Protein Cell"},{"issue":"11","key":"pone.0352437.ref028","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/metabo12111026","article-title":"Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)","volume":"12","author":"VP Guntur","year":"2022","journal-title":"Metabolites"},{"issue":"1","key":"pone.0352437.ref029","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","article-title":"Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle","volume":"19","author":"SJG Knottnerus","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"pone.0352437.ref030","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41598-022-05667-0","article-title":"Metabolomics study of COVID-19 patients in four different clinical stages","volume":"12","author":"A Vald\u00e9s","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0352437.ref031","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12879-022-07582-1","article-title":"The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis","volume":"22","author":"AF Almulla","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0352437.ref032","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12879-021-06313-2","article-title":"Sex-based clinical and immunological differences in COVID-19","volume":"21","author":"B Huang","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0352437.ref033","doi-asserted-by":"crossref","first-page":"17559","DOI":"10.1038\/s41598-017-17979-7","article-title":"Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives","volume":"7","author":"GS Jayawickrama","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0352437.ref034","doi-asserted-by":"crossref","first-page":"101482","DOI":"10.1016\/j.redox.2020.101482","article-title":"Sex differences in inflammation, redox biology, mitochondria and autoimmunity","volume":"31","author":"DN Di Florio","year":"2020","journal-title":"Redox Biol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0354449","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:27:19Z","timestamp":1782408439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352437"}},"subtitle":[],"editor":[{"given":"Anil","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0352437","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}